within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DC01_Cefoxitin;

model Cefoxitin
  extends Pharmacolibrary.Drugs.ATC.J.J01DC01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01DC01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefoxitin is a second-generation cephalosporin antibiotic with activity against a broad spectrum of Gram-positive and Gram-negative bacteria, including anaerobes. It is primarily used to treat bacterial infections such as intra-abdominal infections, gynecological infections, and prophylaxis in surgical procedures. Cefoxitin is an approved and widely used drug in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Albarellos, GA, et al., &amp; Landoni, MF (2010). Pharmacokinetics of cefoxitin after intravenous and intramuscular administration to cats. <i>Journal of veterinary pharmacology and therapeutics</i> 33(6) 619–621. DOI:<a href=\"https://doi.org/10.1111/j.1365-2885.2010.01179.x\">10.1111/j.1365-2885.2010.01179.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21108508/\">https://pubmed.ncbi.nlm.nih.gov/21108508</a></p></li><li><p>Buchanan, N, et al., &amp; Witcomb, M (1980). Cefoxitin: intravenous pharmacokinetics and intramuscular bioavailability in kwashiorkor. <i>British journal of clinical pharmacology</i> 9(6) 623–627. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1980.tb01093.x\">10.1111/j.1365-2125.1980.tb01093.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7387820/\">https://pubmed.ncbi.nlm.nih.gov/7387820</a></p></li><li><p>Flaherty, JF, et al., &amp; Elliott, JP (1983). Pharmacokinetics of cefoxitin in patients at term gestation: lavage versus intravenous administration. <i>American journal of obstetrics and gynecology</i> 146(7) 760–766. DOI:<a href=\"https://doi.org/10.1016/0002-9378(83)91073-6\">10.1016/0002-9378(83)91073-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6346881/\">https://pubmed.ncbi.nlm.nih.gov/6346881</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Cefoxitin;
